Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Alpha Cognition Inc. (ACOGF) Insider Trading Activity
Healthcare • Biotechnology • 0 employees
Alpha Cognition Inc., a clinical stage biopharmaceutical company, develops treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
Total Value
$89,987.50
Total Shares
15,650
Average Trade Value
$29,995.83
Most Active Insider
Mertz Leonard Powell
Total Activity: $49,996
Largest Single Transaction
$49,996
by Mertz Leonard Powell on Nov 13, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Nov 13, 2024 | 8,695 | $49,996 | 93,725 (+9.3%) | Purchase | ||
| Nov 13, 2024 | 4,347 | $24,995 | 273,272 (+1.6%) | Purchase | ||
|
Chief Executive Officer
|
Nov 13, 2024 | 2,608 | $14,996 | 14,142 (+18.4%) | Purchase |